Growth Metrics

Bio-Techne (TECH) Assets Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.54%
Dec 31, 2025 -5.53%
Sep 30, 2025 -7.67%
Jun 30, 2025 -5.40%
Mar 31, 2025 -2.83%
Dec 31, 2024 -2.21%
Sep 30, 2024 -0.70%
Jun 30, 2024 2.47%
Mar 31, 2024 4.67%
Dec 31, 2023 15.54%
Sep 30, 2023 17.21%
Jun 30, 2023 14.99%
Mar 31, 2023 13.04%
Dec 31, 2022 2.54%
Sep 30, 2022 3.55%
Jun 30, 2022 1.41%
Mar 31, 2022 10.33%
Dec 31, 2021 11.46%
Sep 30, 2021 10.57%
Jun 30, 2021 11.61%
Mar 31, 2021 4.28%
Dec 31, 2020 3.48%
Sep 30, 2020 6.65%
Jun 30, 2020 7.60%
Mar 31, 2020 6.75%
Dec 31, 2019 8.33%
Sep 30, 2019 2.82%
Jun 30, 2019 18.28%
Mar 31, 2019 15.75%
Dec 31, 2018 18.61%
Sep 30, 2018 22.58%
Jun 30, 2018 2.25%
Mar 31, 2018 5.50%
Dec 31, 2017 2.33%
Sep 30, 2017 0.65%
Jun 30, 2017 37.95%
Mar 31, 2017 36.68%
Dec 31, 2016 34.11%
Sep 30, 2016 34.49%
Jun 30, 2016 6.23%
Mar 31, 2016 1.60%
Dec 31, 2015 1.29%
Sep 30, 2015 10.81%
Jun 30, 2015 23.29%
Mar 31, 2015 32.96%
Dec 31, 2014 39.50%
Sep 30, 2014 30.67%
Jun 30, 2014 10.85%
Mar 31, 2014 9.24%
Dec 31, 2013 10.71%
Sep 30, 2013 9.35%
Jun 30, 2013 8.17%
Mar 31, 2013 11.15%
Dec 31, 2012 16.07%
Sep 30, 2012 13.40%
Jun 30, 2012 16.46%
Mar 31, 2012 17.37%
Dec 31, 2011 12.35%
Sep 30, 2011 16.46%
Jun 30, 2011 19.05%
Jun 30, 2010 9.92%